Company intelligence / Profile preview

Weatherwax Biotechnologies

San Francisco, California, USA

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Weatherwax Biotechnologies is a seed-stage biotech developing a proprietary induced-proximity small‑molecule platform (bifunctional molecules) to reactivate mutant p53 and advance next‑generation oncology therapeutics, currently at preclinical/early discovery stage supported by an NIH SBIR Phase I award focused on triple‑negative breast cancer.[3][4][7][9]

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Partnerships

Astellas (Astellas Future Innovator Prize – research support)[4][8]MBC BioLabs (incubator/lab space partnership)[4][8]California Life Sciences FAST advisory program[7]

Beyond the preview

Go deeper on Weatherwax Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weatherwax Biotechnologies.

Explore the full profile